GT Biopharma, Inc. (GTBP)
GTBP
Loading signal…
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $8M
- Short % float
- 2.52%
- Days to cover
- 4.4
- SI change
- +1.1%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FAQ
- What is LOPJLB’s current signal on GTBP?
- LOPJLB publishes daily direction and regime signals for GTBP on this page.
- What market regime is GTBP in?
- LOPJLB classifies each ticker into BULL, RECOVERY, BEAR, or CRISIS regimes using a Hidden Markov Model.
- What does GT Biopharma, Inc. (GTBP) do?
- GT Biopharma, Inc. is a biopharmaceutical company in the clinical development phase, dedicated to discovering and bringing to market novel immuno-oncology treatments. Their innovative approach centers on a proprietary technology platform called Tri-specific Killer Engager (TriKE) fusion proteins, which are designed to harness the body's immune cells. Central to their pipeline is GTB-3550, a sin…